BMO lowers Novo Nordisk's target price to $40
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, October 14th — BMO Capital has lowered Novo Nordisk's target price from $47 to $40, maintaining a "market perform" rating.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NEAR Claims Crown in Crypto's Pivot to AI: Wintermute
UToday•2026/10/14 10:00
Cardano Visa Multi-Chain Crypto Card Announces Sunset, Key Date for ADA Holders
UToday•2026/10/14 10:00
Euro: Positioning turns net short – BNY
FXStreet•2026/10/14 09:48
